Jeffrey W. Albers - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey W. Albers since 27 Dec 2024

Holdings reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 27.4K $1.01M $36.76 06 Nov 2024 By Sessions LLC
Stock Option (Right to Buy) 25K 29 May 2025 Direct Common Stock

Transactions reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.